Written by Amanda Glassman and Prashant Yadav
Last week, the European Union and its member states placed a “European global health strategy” at the top of their shared agenda. And as part of the EU-Africa summit this week in Brussels, the EU is highlighting its support for regional manufacturing of COVID-19 vaccine via the African Union’s Partnership for African Vaccine Manufacturing (PAVM) as a major piece of the overall agenda. Sub-Saharan African countries currently import 99 percent of their vaccines, and the EU seem to be acknowledging that ensuring that Africa has autonomy over its own health security is important, announcing over €1 billion in cash plus in-kind expertise for PAVM, with more on the way.
Gain access to all our Premium contents.
More than 100+ articles.